Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 2,701-2,712 of 10,612

Drug study icon

CompletedNCT05593029

A study of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Canada, Bulgaria, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Depression

Device study icon

Active Not RecruitingNCT05102864

A study of Two-Week Brain Stimulation for Teenagers With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDeviceFrom 12 Years to 18 Years

Countries: United States
Sponsor: Bradley Hospital
Condition: ADHD

Drug study icon

CompletedNCT06372210

A study to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, Schizophrenia, ...DrugOver 18 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Depression, Schizophrenia, ...

Drug study icon

CompletedNCT03259555

A study to Assess Brexpiprazole Versus Placebo for Acute manic episodes Associated With Bipolarity type I

This study is completed in the United States, in Bulgaria, in Poland, .... It focuses on manic episodes in bipolarity type I.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Poland, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT03257865

A study to Assess Brexpiprazole Versus Placebo for Acute manic episodes, Associated With Bipolarity type I

This study is completed in the United States, in Croatia, and in Ukraine. It focuses on manic episodes in bipolarity type I.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Croatia, Ukraine
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity

Drug study icon

CompletedNCT07314333

A study to Assess How Centanafadine Interacts With Stimulants in the Body

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: ADHD

Drug study icon

CompletedNCT02282761

A study to Assess the Antipsychotic Efficacy of ITI-007

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT02469155

A study to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Schizophrenia

Drug study icon

TerminatedNCT05189977

A study to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: PTSD

Drug study icon

CompletedNCT04786730

A study to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder

This study is completed in the United States. It focuses on ADHD.

In United States

ADHDDrugFrom 4 Years to 12 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: ADHD

Drug study icon

CompletedNCT04398225

A study to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 4 Years to 12 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: ADHD

Drug study icon

CompletedNCT07253441

A study to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood Levels

This study is completed in the United States. It focuses on ADHD.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.